U.S. Neurosurgical Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 13, 2020 at 04:45 pm EST
Share
U.S. NeuroSurgical Holdings, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 662,000 compared to USD 658,000 a year ago. Operating income was USD 284,000 compared to USD 292,000 a year ago. Net income was USD 164,000 compared to USD 115,000 a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago. For the nine months, sales was USD 2.005 million compared to USD 2.324 million a year ago. Operating income was USD 788,000 compared to USD 1.115 million a year ago. Net income was USD 384,000 compared to USD 242,000 a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to USD 0.03 a year ago.
U.S. NeuroSurgical Holdings, Inc., through its wholly-owned subsidiaries, holds interests in radiological treatment facilities. The Company owns and operates stereotactic radiosurgery centers, utilizing gamma knife technology. It owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility, where the unit is housed and maintained, based on utilization. It is also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy capabilities. It is focused on launching and development of Medicare advantage plans for seniors by its subsidiaries, Elite Health Plan and Elite Health Plan of Nevada, Inc. Medicare is the federal health insurance program for people ages 65 and over, to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant.
U.S. NEUROSURGICAL HOLDINGS, INC. 
